Max Robotics — Global Service Robot Directory + US Certification

About

Rabie M. Shanti is a leading head and neck surgical oncologist and researcher whose work centers on the treatment of HPV-related oropharyngeal cancers, with a particular focus on refining surgical outcomes and predicting disease recurrence. His most-cited study, a 2022 benchmark analysis of oncologic outcomes following transoral robotic surgery (TORS), established a critical model for assessing lethal recurrence risk in this patient population. This work has been cited 16 times and is widely recognized for providing surgeons with a more precise framework for postoperative surveillance and risk stratification. Dr. Shanti’s contributions are notable for bridging the gap between advanced surgical techniques and evidence-based prognostic tools, directly improving clinical decision-making for patients with HPV-positive oropharyngeal cancer. His research has helped define contemporary standards for TORS outcomes, making him a key voice in the evolution of minimally invasive head and neck cancer surgery. For students and researchers, his work exemplifies how targeted clinical research can translate into tangible improvements in oncologic care.